DE60129032D1 - Creatinester-pronutrient-verbindungen und formulierungen - Google Patents

Creatinester-pronutrient-verbindungen und formulierungen

Info

Publication number
DE60129032D1
DE60129032D1 DE60129032T DE60129032T DE60129032D1 DE 60129032 D1 DE60129032 D1 DE 60129032D1 DE 60129032 T DE60129032 T DE 60129032T DE 60129032 T DE60129032 T DE 60129032T DE 60129032 D1 DE60129032 D1 DE 60129032D1
Authority
DE
Germany
Prior art keywords
creatinester
formulations
pronutrient
compounds
creatine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60129032T
Other languages
English (en)
Other versions
DE60129032T2 (de
Inventor
Jonathan L Vennerstrom
Donald W Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Nebraska
Original Assignee
University of Nebraska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Nebraska filed Critical University of Nebraska
Application granted granted Critical
Publication of DE60129032D1 publication Critical patent/DE60129032D1/de
Publication of DE60129032T2 publication Critical patent/DE60129032T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/105—Aliphatic or alicyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/10—Shaping or working-up of animal feeding-stuffs by agglomeration; by granulation, e.g. making powders
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
DE60129032T 2000-09-14 2001-09-14 Creatinester-pronutrient-verbindungen und formulierungen Expired - Lifetime DE60129032T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23296900P 2000-09-14 2000-09-14
US232969P 2000-09-14
PCT/US2001/028788 WO2002022135A1 (en) 2000-09-14 2001-09-14 Creatine ester pronutrient compounds and formulations

Publications (2)

Publication Number Publication Date
DE60129032D1 true DE60129032D1 (de) 2007-08-02
DE60129032T2 DE60129032T2 (de) 2008-02-21

Family

ID=22875316

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60129032T Expired - Lifetime DE60129032T2 (de) 2000-09-14 2001-09-14 Creatinester-pronutrient-verbindungen und formulierungen

Country Status (13)

Country Link
EP (1) EP1324760B1 (de)
JP (1) JP5180421B2 (de)
KR (1) KR100868592B1 (de)
AT (1) ATE365036T1 (de)
AU (2) AU9093901A (de)
CA (1) CA2420562C (de)
DE (1) DE60129032T2 (de)
DK (1) DK1324760T3 (de)
ES (1) ES2288990T3 (de)
MX (1) MXPA03002068A (de)
NO (1) NO20030937L (de)
NZ (1) NZ524510A (de)
WO (1) WO2002022135A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9833427B2 (en) * 2000-09-14 2017-12-05 Board Of Regents Of The University Of Nebraska Creatine ester anti-inflammatory compounds and formulations
US8354450B2 (en) 2003-05-15 2013-01-15 Vireo Systems, Inc. Creatine oral supplementation using creatine hydrochloride salt
US7608641B2 (en) 2003-05-15 2009-10-27 Board Of Regents Of The University Of Nebraska Creatine oral supplementation using creatine hydrochloride salt
US6897334B2 (en) 2003-08-25 2005-05-24 Board Of Regents Of The University Of Nebraska Production of creatine esters using in situ acid production
ITTO20050847A1 (it) * 2005-11-30 2007-06-01 Sergey Vladimirovich Burov Complessi di fosfocreatina
KR101015607B1 (ko) * 2008-05-29 2011-02-16 신동익 피엘램프용 교환장치
EP2269980A4 (de) 2008-12-24 2011-05-18 Vertex Closed Joint Stock Company Creatinamide, verfahren zu ihrer herstellung und wirkstoff zur ausführung einer neuroprotektiven aktion
DK2692719T3 (en) 2012-07-30 2016-09-12 Commissariat L Energie Atomique Et Aux Energies Alternatives A process for the preparation of kreatinfedtestere, thus prepared and to their use kreatinfedtestere
AU2014346952A1 (en) * 2013-11-05 2016-05-26 Ultragenyx Pharmaceutical Inc. Creatine analogs and the use thereof
US9993452B2 (en) 2014-12-05 2018-06-12 Vireo Systems, Inc. Compositions and methods for treatment of inflammation
EP3563830A1 (de) 2018-05-03 2019-11-06 Commissariat à l'énergie atomique et aux énergies alternatives Mikroemulsion mit kreatinfettsäureester, verfahren zur herstellung der besagten mikroemulsion und verwendungen davon
EP3732995A1 (de) 2019-04-30 2020-11-04 Commissariat à l'énergie atomique et aux énergies alternatives Zusammensetzung mit kreatinfettester zur verwendung in der medizin

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9215746D0 (en) * 1992-07-24 1992-09-09 Hultman Eric A method of increasing creatine supply depot
WO1994016687A1 (en) * 1993-01-28 1994-08-04 The Trustees Of The University Of Pennsylvania Use of creatine or analogs for the manufacture of a medicament for inhibiting tumor growth
JP3595373B2 (ja) * 1995-02-20 2004-12-02 治彦 末岡 クレアチン飲料
IT1275434B (it) * 1995-05-19 1997-08-07 Farmila Farma Milano Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
US5773473A (en) * 1997-04-15 1998-06-30 Green; Jerold L. Creatine supplement
DE19748696A1 (de) * 1997-11-04 1999-05-06 Basf Ag Verfahren zur Herstellung von substituierten Guanidinderivaten
US5994581A (en) * 1998-03-09 1999-11-30 Amt Labs, Inc. Carnitine creatinate
WO1999051097A1 (en) * 1998-04-02 1999-10-14 Avicena Group, Inc. Compositions containing a combination of a creatine compound and a second agent
US6117872A (en) * 1998-06-23 2000-09-12 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of exercise performance by augmenting endogenous nitric oxide production or activity
US6136339A (en) * 1998-08-21 2000-10-24 Gardiner; Paul T. Food supplements and methods comprising lipoic acid and creatine
EP1002532A1 (de) * 1998-11-19 2000-05-24 K.U. Leuven Research & Development Vorbeugung von Alterungserscheinungen und Behandlung der Muskelatrophie
EP2162126A4 (de) * 2007-06-05 2013-08-28 Cryxa Llc Magensaftresistent beschichtete lösliche creatin- und polyethylenglykol-zusammensetzung zur verbesserung der knochenaufnahme von oralem creatin

Also Published As

Publication number Publication date
NO20030937L (no) 2003-04-24
CA2420562A1 (en) 2002-03-21
JP5180421B2 (ja) 2013-04-10
AU9093901A (en) 2002-03-26
WO2002022135A1 (en) 2002-03-21
DK1324760T3 (da) 2007-07-16
DE60129032T2 (de) 2008-02-21
EP1324760B1 (de) 2007-06-20
ATE365036T1 (de) 2007-07-15
MXPA03002068A (es) 2004-09-10
AU2001290939B2 (en) 2005-06-16
NZ524510A (en) 2005-08-26
EP1324760A1 (de) 2003-07-09
ES2288990T3 (es) 2008-02-01
EP1324760A4 (de) 2005-08-10
JP2004508407A (ja) 2004-03-18
KR20030029994A (ko) 2003-04-16
CA2420562C (en) 2011-03-29
KR100868592B1 (ko) 2008-11-13
NO20030937D0 (no) 2003-02-28

Similar Documents

Publication Publication Date Title
BR9804214A (pt) Compostos.
EA200300429A1 (ru) Способ получения порошковых композиций
ATE289640T1 (de) Amidofunktionelle aminopolydiorganosiloxane
EA199900373A2 (ru) Фармацевтические композиции
CY2007029I1 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
EA200300566A1 (ru) Применение cci-779 в качестве противоопухолевого средства
DE60139614D1 (de) Verfahren zur s.i.p/h.323-zusammenarbeit
ECSP095220A (es) Derivados de n-fenil-2-pirimidin-amina
PT1305286E (pt) Ciclopentanoindoles composicoes que contem os referidos compostos e metodos de tratamento
DE602004005890D1 (de) Moschus-geruchsstoffe
DE60129032D1 (de) Creatinester-pronutrient-verbindungen und formulierungen
SE9901077D0 (sv) Novel use
ATE338047T1 (de) Stickstoffbasierte camptothecin-derivate
SV2003000981A (es) Fenil-heterociclil-eteres ref. pcs10973
DE60025494D1 (de) Epothilon zusammensetzungen
CY1106712T1 (el) Υποκατεστημενα παραγωγα 5-αμινο-1-πεντεν-3-ολης
CY1105699T1 (el) Νεες φαρμακευτικες ενωσεις με αλφα2υποδοχεα δραστηριοτητας
ATE295686T1 (de) Zusammensetzungen zur abschreckung kriechender insekten
PT1339703E (pt) Processo para a preparacao de paclitaxel
BR0101437A (pt) Método para preparar um ciclopropeno
GB9906458D0 (en) Compound
AR025028A1 (es) Procedimiento para preparar acidos a traves de alfa-cloroepoxi-esteres
MXPA03005400A (es) Metodo para preparacion de 11 (12)-pentadecen-15-olidos.
PA8615401A1 (es) Metodos para la preparacion del acido {2-[(8,9)-dioxo-2, 6-diaza-biciclo[5.2.0]-non-1(7)-en-2-il]etil} fosfonico y esteres del mismo
NO20020328L (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol

Legal Events

Date Code Title Description
8364 No opposition during term of opposition